![Influenza Series: Evolution of treatment options]()
by MyBiosource Editorial Team | Nov 13, 2018 | News
Anti-influenza treatments are vital particularly when vaccine efficacy is low or unavailable. In several countries, antiviral drugs are given to hospitalized individuals with severe influenza illness, although certain countries such as Japan and China continue to...
by MyBiosource Editorial Team | Oct 24, 2018 | News
Table of Contents I. Introduction • Identification of active virus as influenza A(H1N1)pdm09 • Overview of influenza as a global illness and cause of death II. Antiviral Treatment Recommendations • Five licensed prescription antiviral drugs in the US • Neuraminidase...
by MyBiosource Editorial Team | Oct 21, 2018 | News
Table of Contents 1. Introduction 2. Severe Illness and Death Caused by Influenza 3. Influenza Vaccination in Canada 4. Antiviral Drugs for Chemoprophylaxis and Influenza Illness Therapy in Pediatric and Adult Settings 5. Trivalent Inactivated Vaccines (TIV) and Live...
by MyBiosource Editorial Team | Oct 20, 2018 | News
Table of Contents 1. Introduction 2. Influenza Virus Morphology • Pleomorphic with spherical or filamentous morphology • Enveloped virus with outer lipid membrane and embedded proteins 3. Influenza Virus Genome • Segmented negative-sense RNA core • Eight RNA segments...
by MyBiosource Editorial Team | Oct 15, 2018 | News
Table of Contents I. Introduction • Scabies as a common dermatological problem • Prevalence of Scabies infection in developing countries and globally • Vulnerability of young and old individuals with low economic resources • Impact of hot and tropical climate II....
